Charles River Laboratories | CRL - Loan Capital

Stock Price
166.79
Daily Change
-4.44 -2.59%
Monthly
4.43%
Yearly
42.20%
Q2 Forecast
166.17

Charles River Laboratories reported $2.14B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.05B 0 Dec/2025
Align Technology USD 0 0 Dec/2024
Bio-Rad Laboratories USD 1.2B 300K Dec/2025
Bruker USD 1.85B 131.7M Dec/2025
Cardinal Health USD 8.35B 633M Dec/2025
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Cigna USD 30.95B 4.47B Sep/2025
Concord Medical Services Hldg CNY 2.27B 3.79M Jun/2025
CVS Health USD 60.5B 6M Dec/2025
Danaher USD 17.56B 855M Mar/2026
Dentsply International USD 2.02B 2M Dec/2025
Elevance Health USD 30.77B 29M Mar/2026
Galapagos EUR 5.19M 574K Dec/2025
Humana USD 12.37B 238M Dec/2025
Illumina USD 1.49B 496M Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
Intrexon USD 0 198.67M Jun/2024
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Laboratory Of America USD 5.15B 800K Dec/2025
Lonza CHF 3.88B 323M Dec/2025
McKesson USD 5.43B 586M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Quest Diagnostics USD 5.16B 12M Mar/2026
Revvity USD 2.63B 543K Dec/2025
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
United Therapeutics USD 100M 100M Jun/2024
UnitedHealth USD 71.44B 880M Mar/2026
Veradigm USD 200.4M 69K Dec/2022
Waters USD 1.41B 460.24M Dec/2025
West Pharmaceutical Services USD 202.8M 0 Mar/2026